| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 35.218 | 30.473 | 25.128 | 25.569 | 26.823 | 25.263 | 28.188 | 35.575 | 32.512 | 27.381 |
| Total Income - EUR | 35.219 | 30.473 | 25.073 | 27.059 | 26.823 | 25.263 | 28.188 | 35.575 | 32.512 | 27.988 |
| Total Expenses - EUR | 57.820 | 45.853 | 40.210 | 37.646 | 40.259 | 33.977 | 35.360 | 42.569 | 46.515 | 38.049 |
| Gross Profit/Loss - EUR | -22.601 | -15.380 | -15.136 | -10.587 | -13.436 | -8.714 | -7.172 | -6.994 | -14.003 | -10.061 |
| Net Profit/Loss - EUR | -23.657 | -16.294 | -15.889 | -11.399 | -14.245 | -9.435 | -8.035 | -8.085 | -14.003 | -10.061 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Uro - Litho - Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 180.204 | 164.559 | 148.302 | 132.557 | 117.218 | 104.554 | 94.726 | 83.636 | 72.027 | 60.586 |
| Current Assets | 4.916 | 3.337 | 1.978 | 2.441 | 1.923 | 2.421 | 2.532 | 4.279 | 3.386 | 1.761 |
| Inventories | 1.466 | 11 | 0 | 752 | 0 | 122 | 119 | 242 | 92 | 0 |
| Receivables | 757 | 555 | 357 | 142 | 379 | 474 | 404 | 359 | 1.825 | 201 |
| Cash | 2.692 | 2.771 | 1.620 | 1.547 | 1.544 | 1.825 | 2.008 | 3.678 | 1.469 | 1.560 |
| Shareholders Funds | -48.409 | -64.210 | -79.012 | -88.961 | -101.482 | -108.994 | -114.612 | -123.053 | -136.683 | -145.980 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 233.529 | 232.519 | 229.391 | 224.032 | 220.695 | 216.039 | 211.939 | 211.037 | 212.165 | 208.327 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Uro - Litho - Med Srl